ISTA Pharma says Xibrom QD eliminated eye inflammation and eye pain after cataract surgery

ISTA says daily Xibrom eye drops met goal in study

IRVINE, Calif. — ISTA Pharmaceuticals Inc. on Wednesday reported successful late-stage clinical trial results for Xibrom QD, a new once-per-day eye drug.

Full article »


Protected by Comment Guard Pro